[3์ฃผ์ฐจ]

[4์ฃผ์ฐจ]

์ƒ๋ถ€ ์†Œํ™”๊ธฐ ์งˆํ™˜

2.1 Acute gastritis (๊ธ‰์„ฑ ์œ„์—ผ)

Etiology

  • ๊ฐ•์•„์ง€์—์„œ ์ž˜ ์ƒ๊น€. (๊ณ ์–‘์ด์—์„œ๋Š” ๋งŒ์„ฑ ์œ„์—ผ์ด ๋”)
  • ์˜ค์—ผ๋œ ์Œ์‹
  • ์ด๋ฌผ, ๋…์„ฑ ์‹๋ฌผ
  • Chemicals - ๋ณดํ˜ธ์ž ์•ฝ๋ฌผ์„ ์ฃผ์›Œ๋จน๊ฑฐ๋‚˜
  • Irritating drugs - NSAIDs ์•ฝ๋ฌด๋  ์˜ํ•ด prostaglandin E1 ๊ฐ์†Œ, ํ† ํ•˜๊ณ  ํ•˜๋ฉด์„œ ๊ธ‰์„ฑ ์œ„์—ผ

Clinical Features

  • Vomiting (acute), anorexia : ๊ฒฝ๊ณผ๊ฐ€ ๋น ๋ฅด๊ณ , ์ „์‹ ์ ์ธ ์ฆ์ƒ๊นŒ์ง€๋Š” X
    • ๋ฐœ์—ด, ๋ณต๋ถ€ ํ†ต์ฆ ๊ฐ™์€ ์ฆ์ƒ์€ ์ž˜ ์—†์Œ

Diagnosis

  • History taking, P/E : ๋ฌธ์ง„๊ณผ ์‹ ์ฒด๊ฒ€์‚ฌ๊ฐ€ ๊ฐ€์žฅ ์ค‘์š”
  • ๊ตถ๊ธฐ๊ฑฐ๋‚˜ ์ฃฝ์„ ๋จน์ด๊ณ  ํ•˜๋ฃจ์ดํ‹€ ์ •๋„ ๊ฒฝ๊ณผ๋ฅผ ์ง€์ผœ๋ด„. ๋ณดํ†ต ์ข‹์•„์ง.
  • ๋” ์•ˆ ์ข‹์•„์ง€๋ฉด ๊ฒ€์‚ฌ๋ฅผ ํ•จ (Abdominal imaging, Blood work)

Treatment

  • Withholding food and water for 24h : ํ•˜๋ฃจ์ดํ‹€ ์ •๋„ ๊ตถ๊น€
    • Parental fluid : ๊ฐ•์•„์ง€๊ฐ€ ๋„ˆ๋ฌด ์ž‘๊ฑฐ๋‚˜ ํ˜ˆ์••์ด ๋‚ฎ์œผ๋ฉด ๋น„๊ฒฝ๊ตฌ์  ์ˆ˜์•ก ์ฒ˜์น˜
  • Central-acting antiemetics : ์ค‘์ถ”์„ฑ ํ•ญ๊ตฌํ† ์ œ(maropitant, ondansetron)๋ฅผ ๋น„๊ฒฝ๊ตฌ์ ์œผ๋กœ ํˆฌ์•ฝ.
  • Small amounts of water : ๋ฌผ์€ ์†Œ๋Ÿ‰์”ฉ
  • Bland diet : ๊ณ ๋‹จ๋ฐฑ ์‹์ด (์ฝ”ํ‹ฐ์ง€ ์น˜์ฆˆ, ๊ฐ์‚ฌ, ์‚ถ์€ ๋‹ญ๊ณ ๊ธฐ)
  • ํ•ญ์ƒ์ œ๋‚˜ ์Šคํ…Œ๋กœ์ด๋“œ๋Š” ๋ณดํ†ต ์ฒ˜๋ฐฉํ•˜์ง€ ์•Š๋Š”๋‹ค.

Prognosis

Excellent - ํ•˜๋ฃจ ์ดํ‹€ ๊ตถ๊ธฐ๋ฉด ์ข‹์•„์ง.


๊น€๋‚ด2(A) - Antiemetics (ํ•ญ๊ตฌํ† ์ œ)

Antiemetics (ํ•ญ๊ตฌํ† ์ œ)

Peripherally acting (๋ง์ดˆ์„ฑ ํ•ญ๊ตฌํ† ์ œ)

  • Less effective, parasympatholytics
  • atropine, aminopentamide
  • ์œ„์˜ ๋ฏธ์ฃผ์‹ ๊ฒฝ์ด ์ž๊ทน๋˜์–ด ๊ตฌํ† ๊ฐ€ ์œ ๋ฐœ๋˜๊ธฐ ๋•Œ๋ฌธ์—, vagolytic(๋ฏธ์ฃผ์‹ ๊ฒฝ ์–ต์ œ) ์•ฝ์„ ์”€.
  • ๊ตฌํ† ๋ฅผ ์–ต์ œํ•˜๋ ค๊ณ  ์“ฐ๊ธฐ๋ณด๋‹จ, ๋งˆ์ทจํ•  ๋•Œ ํƒ€์•ก ์ค„์ž„ + ๊ตฌํ†  ์–ต์ œ ์œ„ํ•ด ์ „๋งˆ์ทจ์ œ๋กœ ์“ธ ์ˆ˜ ์žˆ์Œ.

Centrally acting (์ค‘์ถ”์„ฑ ํ•ญ๊ตฌํ† ์ œ)

  • More reliable, preferred parenteral route
  • ํšจ๊ณผ๊ฐ€ ์ข‹๊ณ , ๋น„๊ฒฝ๊ตฌ์  ํˆฌ์—ฌ๊ฐ€ ์„ ํ˜ธ๋จ
  • Suppositories (์ขŒ์•ฝ; ์ง์žฅ ํˆฌ์—ฌ) - ํก์ˆ˜๊ฐ€ ์ผ์ •ํ•˜์ง€ ์•Š์Œ(erratic absorption), ๋™๋ฌผ์—์„œ๋Š” ๋น„์ถ”์ฒœ.

Maropitant [Cerenia]

  • Neurokinin-1 (NK-1) receptor antagonist

    • ์—ฐ์ˆ˜์˜ ๊ตฌํ† ์ค‘์ถ”(NK-1)์— substance P๊ฐ€ ๊ฒฐํ•ฉํ•˜๋ฉด ๊ตฌํ† , ์—ผ์ฆ, ํ†ต์ฆ์ด ์œ ๋ฐœ๋จ.
    • Maropitant๋Š” substance P์™€ ์œ ์‚ฌํ•œ ๊ตฌ์กฐ โ†’ NK-1์— ๊ฒฝ์Ÿ์ ์œผ๋กœ ๊ฒฐํ•ฉ โ†’ ๊ตฌํ†  ์œ ๋ฐœ์„ ์–ต์ œํ•จ.
  • ๊ฒฝ๊ตฌ์ œ โ†’ ์ƒ์ฒด์ด์šฉ๋ฅ  ๋‚ฎ์Œ. SC, ์ฃผ์‚ฌ์ œ๊ฐ€ ์ถ”์ฒœ๋จ. (1mg/kg SC/PO, SID)

  • ํšจ๊ณผ๊ฐ€ ๋งค์šฐ ์ข‹๊ณ , ๋ถ€์ž‘์šฉ๋„ ํฌ๊ฒŒ ์—†์Œ.

  • ๊ทธ๋Ÿฌ๋‚˜ ์ถ•์ ๋˜๋ฉด ๋ฌธ์ œ๋  ์ˆ˜ ์žˆ์œผ๋ฏ€๋กœ 5์ผ ์ด์ƒ ์“ฐ์ง€ ์•Š์Œ. ๊ณ„์† ์จ์•ผ ํ•  ๊ฒฝ์šฐ, ์ตœ์†Œ ์ดํ‹€์€ ํœด์•ฝํ•ด์•ผ ํ•จ.

  • Contraindication | puppies < 11 weeks (๊ณจ์ˆ˜ ์–ต์••์„ ์ผ์œผํ‚ค๊ธฐ ๋•Œ๋ฌธ์— 3๊ฐœ์›” ์ดํ•˜ ๊ฐ•์•„์ง€๋Š” ์‚ฌ์šฉ ๊ธˆ์ง€. ํŒŒ๋ณด ์น˜๋ฃŒ์— ์‚ฌ์šฉ ๋ถˆ๊ฐ€.)

Ondansetron [Zofran] & Dolasetron [Anzemet]

  • Serotonin(= 5-hydroxytryptamine, 5-HT) receptor antagonists

    • 5-HT receptor๋Š” ์—ฐ์ˆ˜์˜ CRTZ(chemoreceptor trigger zone), ๊ตฌํ† ์ค‘์ถ”์— ์œ„์น˜ํ•จ.
    • Serotonin์€ ๋‹ค์–‘ํ•œ receptor์— ์ž‘์šฉํ•˜๋Š”๋ฐ, subtype 3 receptor์— ์ž‘์šฉํ•˜๋ฉด ๊ตฌํ† ๋ฅผ ์œ ๋ฐœํ•จ.
    • Ondansetron์€ ์ด ๊ฒฝ๋กœ๋ฅผ ์ฐจ๋‹จํ•˜์—ฌ ๊ตฌํ†  ์–ต์ œ ํšจ๊ณผ.
  • Canine Pavoviral enteritis์—๋„ ํ•ญ๊ตฌํ†  ๋ชฉ์ ์œผ๋กœ ์‚ฌ์šฉ ๊ฐ€๋Šฅ.

  • ๋Œ€๋ถ€๋ถ„ ์ฃผ์‚ฌ์ œ๋กœ ์‚ฌ์šฉ. ๊ฒฝ๊ตฌ ์ œ์ œ๋„ ์žˆ์Œ. (Ondansetron @ 0.1-0.2 mg/kg IV, SID to TID)

  • ๋น„์šฉ์ด ๋งค์šฐ ๋น„์‹ธ๋‹ค.

Mirtazapine

  • 5-HT receptor antagonist
    • Serotonin์ด subtype 2 receptor์— ์ž‘์šฉํ•˜๋ฉด ํฌ๋งŒ๊ฐ ์œ ๋ฐœ, ๊ธฐ๋ถ„์ด ์ข‹์•„์ง.
    • Mirtazapin โ†’ ํฌ๋งŒ ์ค‘์ถ”๊ฐ€ ์–ต์ œ๋˜๋ฉด์„œ ์‹์š• ์ด‰์ง„, ์ง„์ • ํšจ๊ณผ (appetite stimulant - primary ํšจ๊ณผ)
    • Subtype 3๋„ ์•ฝ๊ฐ„ ์–ต์ œํ•˜์—ฌ ํ•ญ๊ตฌํ†  ํšจ๊ณผ๋„ ์žˆ์Œ.
      • Dogs @ 0.5mg/kg PO q24h, Cats @ 3.75mg PO q72h
  • ํ™˜์ž ์‚ถ์˜ ์งˆ์ ์ธ ์ธก๋ฉด์—์„œ ์œ ์˜๋ฏธ.
  • ๋ถ€์ž‘์šฉ์€ ๊ฑฐ์˜ ์—†๋‹ค,

Metoclopramide [Reglan]

  • CRTZ์˜ CNS dopamine receptors antagonist
  • ์œ„์žฅ๊ด€ ์šด๋™์„ฑ ์ฆ๊ฐ€ (gastric tone, peristalsis โ†‘)
  • NK-1/serotonin R antagonists์—๋Š” ๋œ ์ž‘์šฉ โ†’ ํ•ญ๊ตฌํ†  ํšจ๊ณผ๊ฐ€ ํ›จ์”ฌ ์ ์Œ. (๊ณ ์–‘์ด์—์„œ๋Š” ๋”๋”์šฑ)
  • Contraindication | Gastric/duodenal obstruction (Prokinetics โ†’ ์œ„์žฅ๊ด€์— ์ด๋ฌผ ์žˆ์„ ์‹œ ์ ˆ๋Œ€ ์‚ฌ์šฉ ๊ธˆ์ง€!)
  • ๊ตฌํ† ๊ฐ€ ๋„ˆ๋ฌด ์‹ฌํ•  ๋•Œ (severe vomiting) ์ถ”๊ฐ€์ ์œผ๋กœ ์‚ฌ์šฉํ•จ

Phenothiazine derivatives

  • Prochlorperazine [Compazine], Chlorpromazine [Thorazine], Acepromazine
  • CRTZ(chemoreceptor trigger zone)์„ ์–ต์ œ, ๊ณ ์šฉ๋Ÿ‰์—์„œ ์—ฐ์ˆ˜์˜ ๊ตฌํ†  ์ค‘์ถ” ์–ต์ œ
  • ๋ถ€์ž‘์šฉ : vasodilation (๋ง์ดˆ ํ˜ˆ๋ฅ˜ ๊ฐ์†Œ โ†’ ์ €ํ˜ˆ์••), seizure threshold ์ €ํ•˜ (๋ฐœ์ž‘์ด ๋” ์‰ฝ๊ฒŒ ๋ฐœ์ƒ)

Mu-agonists

  • fentanyl, morphine, methadone
  • ํŽœํƒ€๋‹์ด 50-100๋ฐฐ ์ •๋„ ๊ฐ•ํ•œ ์ง„ํ†ต ํšจ๊ณผ
  • ์ฒ˜์Œ์— ๊ตฌํ†  ์œ ๋ฐœ๋  ์ˆ˜ ์žˆ์œผ๋‚˜(CRTZ activation),
  • ์‹œ๊ฐ„์ด ์ง€๋‚˜ ์—ฐ์ˆ˜๋ฅผ ํ†ต๊ณผํ•˜๋ฉด ๊ตฌํ†  ์ค‘์ถ”๊ฐ€ ์™„์ „ํžˆ ์–ต์••๋˜๋ฉด์„œ ๊ตฌํ†  ์–ต์ œ.

Mu-antagonist

  • butorphanol
  • Mu-antagonist์ด์ž Kappa-agonist โ†’ ๋ถ€๋ถ„์ ์œผ๋กœ ์ž‘์šฉํ•˜์—ฌ ์•ฝ๊ฐ„์˜ ํ•ญ๊ตฌํ†  ํšจ๊ณผ
Link to original

2.2 Hemorrhagic gastroenteritis (HGE)

Etiology

  • Unknown : ์žฅ๋‚ด ์„ธ๊ท  ๋ฌธ์ œ๋กœ ์˜ˆ์ƒ์€ ํ•˜์ง€๋งŒ, ์›์ธ์€ ๋ฐํ˜€์ ธ ์žˆ์ง€ ์•Š์Œ.
    • Clostridium, Campylobacter ๋“ฑ ์ถ”์ธก

History

  • ์†Œํ˜•๊ฒฌ์—์„œ ๋งŽ์ด ๋ฐœ๋ณ‘.
  • ์“ฐ๋ ˆ๊ธฐ๋ฅผ ์ฃผ์›Œ๋จน์—ˆ๊ฑฐ๋‚˜ ํ•˜๋Š” ๋ณ‘๋ ฅ์ด ์ „ํ˜€ ์—†๋Š”๋ฐ, ๊ฐ‘์ž๊ธฐ ์•„์ฃผ ์‹ฌํ•˜๊ฒŒ ์„ ํ˜ˆ์˜ ํ”ผ๋ฅผ ํ† ํ•จ.

Clinical features

  • Profuse hematemesis +/- Hematochezia (ํ˜ˆํ†  ๋ฐ ํ˜ˆ๋ณ€)
  • ์ˆ˜๋ถ„ ์†Œ์‹ค์ด ์‹ฌํ•จ. โ†’ ํ”ผ๋ฅผ ์Ÿ๋Š”๋ฐ ํƒˆ์ˆ˜๊ฐ€ ๊ฐ™์ด ์˜จ๋‹ค. (Severe dehydration โ†’ azotemia(prerenal))
  • DIC๋กœ ์ง„ํ–‰๋˜๋ฉด ํ™˜์ž๊ฐ€ ์œ„ํ—˜ํ•  ์ˆ˜ ์žˆ์Œ.
    • ์ €ํ˜ˆ๋Ÿ‰์„ฑ ์‡ผํฌ โ†’ ์กฐ์ง์˜ ์ „๋ฐ˜์ ์ธ ์ €์‚ฐ์†Œ์ฆ โ†’ ํ˜ˆ๊ด€ ๋‚ดํ”ผ์„ธํฌ์— ์†์ƒ โ†’ ์‘๊ณ ์ธ์ž ์ƒ์„ฑ, ๋ฏธ์„ธํ˜ˆ์ „ ๋ฐœ์ƒ โ†’ ์‘๊ณ ์ธ์ž๊ฐ€ ์†Œ์ง„ โ†’ ๋ชธ์— ๊ด‘๋ฒ”์œ„ํ•œ ๋Œ€๋Ÿ‰ ์ถœํ˜ˆ ๋ฐœ์ƒ โ†’ ์ €ํ˜ˆ๋Ÿ‰์„ฑ ์‡ผํฌ, ์ €์‚ฐ์†Œ์ฆ, ํ˜ˆ๊ด€ ๋‚ดํ”ผ์„ธํฌ ์†์ƒ์ด ๋ฐ˜๋ณต.
    • ํ•œ๋ฒˆ ์‹œ์ž‘๋˜๋ฉด ์ค‘๊ฐ„ ๊ณ ๋ฆฌ๋ฅผ ๋Š๊ธฐ๊ฐ€ ์–ด๋ ค์›€. ํ•ญ์‘๊ณ ์ œ๋ฅผ ์“ฐ๊ธฐ๋„ ์–ด๋ ต๊ณ .. ์ˆ˜์•ก์œผ๋กœ ์กฐ์ ˆ์„ ์ž˜ํ•ด์•ผ ํ•˜๊ณ ..
    • ํ˜ˆ๋ฅ˜๋Ÿ‰ ๋ณด์กด ์น˜๋ฃŒ, DIC ์ง„ํ–‰ ๋‹จ๊ณ„์— ๋”ฐ๋ผ ์‘๊ณ ์ธ์ž or ํ•ญ์‘๊ณ ์ œ

Diagnosis

  • Blood test : PCV > 55%, Plasma total protein ์ •์ƒ, Azotemia, Thrombocytopenia (severe)
    • ํ˜ˆํ† +ํƒˆ์ˆ˜๊ฐ€ ๊ฐ™์ด ์™€์„œ, PCV๋Š” ์˜์™ธ๋กœ ์ •์ƒ์ด๊ฑฐ๋‚˜ ์˜คํžˆ๋ ค ์‚ด์ง ๋†’์Œ. (Hemoconcentration)
    • [PCV & ๋‹จ๋ฐฑ์งˆ ์ •์ƒ + Azotemia + ํ˜ˆ์†ŒํŒ ๋งค์šฐ ๊ฐ์†Œ] 4๊ฐ€์ง€ ํŠน์ง•โ—
  • ํŠน์ง•์ ์ธ ์ž„์ƒ ์ฆ์ƒ๋งŒ์œผ๋กœ ์ง„๋‹จ ๊ฐ€๋Šฅ (์ด๋ฌผ์— ์˜ํ•œ ์ฆ์ƒ์ด ์•„๋‹Œ๋ฐ ์œ„ ์ƒํ™ฉ)
    • ํŠนํžˆ Marked hemoconcentration

Treatment

  • Aggressive fluid therapy : DIC, ์‹ ๋ถ€์ „์œผ๋กœ ๊ฐ€์ง€ ์•Š๊ธฐ ์œ„ํ•ด ๊ณต๊ฒฉ์ ์ธ ํƒˆ์ˆ˜ ๊ต์ • ํ•„์š”
    • Crystalloid๋ณด๋‹ค๋Š” Colloids(albumin)์œผ๋กœ ์“ฐ๋Š” ๊ฒŒ ์ข‹๋‹ค. (Crystalloid โ†’ ์•Œ๋ถ€๋ฏผ ์ €ํ•˜, ๋ณต์ˆ˜ ๊ฐ€๋Šฅ์„ฑ)
  • Parenteral antibiotics : ์žฅ๋‚ด์„ธ๊ท ์˜ dysbiosis์— ์˜ํ•œ ๊ฒƒ์œผ๋กœ ์ถ”์ •๋˜๋ฏ€๋กœ, ampicillin, ์•„๋ชจํฌ๋ผ ๊ฐ™์€ ๊ด‘๋ฒ”์œ„ ํ•ญ์ƒ์ œ ํˆฌ์—ฌ.
  • Synthetic colloids or plasma ((hypoalbuminemia ํ™˜์ž์—์„œ)

Prognosis

  • ๋Šฆ์ง€ ์•Š์€ ์ ์ ˆํ•œ ์น˜๋ฃŒ โ†’ ์˜ˆํ›„๋Š” ์ข‹์€ ํŽธ.
  • ์ ์ ˆํžˆ ์น˜๋ฃŒ๋˜์ง€ ๋ชปํ•˜๋ฉด circulatory collapse, DIC, renal failure

2.3 Chronic gastritis

Etiology

  • LP gastritis (Lymphocytic/plasmacytic) : ๋ฆผํ”„๊ตฌ, ํ˜•์งˆ์„ธํฌ ์นจ์œค
    • ๋งŒ์„ฑ์ ์ธ ์ž๊ทน์— ์˜ํ•œ ๋งŒ์„ฑ ์—ผ์ฆ/๋ฉด์—ญ ๋ฐ˜์‘.
    • nonspecific inflammation, ๋ฉด์—ญ ์–ต์ œ์ œ๋ฅผ ์†Œ๋Ÿ‰ ์“ฐ๋ฉด ํšจ๊ณผ๊ฐ€ ํ›จ์”ฌ ์ข‹๋‹ค.
    • ์ด๋ฌผ์ด ๊ณ„์† ์žˆ๊ฑฐ๋‚˜, ํ—ฌ๋ฆฌ์ฝ”๋ฐ•ํ„ฐ ๊ฐ์—ผ(D < C), ์„ ํ˜• ๊ธฐ์ƒ์ถฉ(Physaloptera) ๋“ฑ
    • ๊ฐœ์™€ ๊ณ ์–‘์ด์—์„œ๋Š” helicobacter๊ฐ€ ๋ฐœ๊ฒฌ๋˜์–ด๋„ ์ž„์ƒ ์ฆ์ƒ์ด ์—†์œผ๋ฉด ๊ตณ์ด ์น˜๋ฃŒํ•˜์ง€ ์•Š๊ฑฐ๋‚˜, ์ฆ์ƒ ๊ฐœ์„ ์„ ์œ„ํ•ด ์•ฝ์„ ์“ฐ๋Š” ์ •๋„. ์žˆ๋”๋ผ๋„ ์œ„ํ—˜์— ์ง์ ‘์ ์ธ ์š”์ธ์€ ์•„๋‹ ๋•Œ๊ฐ€ ๋งŽ๋‹ค. (์‚ฌ๋žŒ์—์„œ๋Š” ์ œ๊ท  ์น˜๋ฃŒ)
      • ๊ณ ์–‘์ด์—์„œ LP gastritis๋ฅผ ๋” ์œ ๋ฐœํ•จ.
    • Physaloptera (์„ ํ˜• ๊ธฐ์ƒ์ถฉ) : ๋ถ„๋ณ€๋ณด๋‹ค๋Š” ์œ„๋‚ด์‹œ๊ฒฝ์œผ๋กœ ๊ด€์ฐฐ, ํ† ์‚ฌ๋ฌผ์„ ๊ฐ€์ ธ์˜ค๊ฒŒ ํ•ด์„œ ํ™•์ธ
  • Eosinophilic gastritis : ์•Œ๋Ÿฌ์ง€ ๋ฐ˜์‘
  • Atophic gastritis : ์œ„์ถ•์„ฑ ์œ„์—ผ
    • Chronic gastric inflammatory disease +/- immune mechanisms
    • ๋งŒ์„ฑ์ ์ธ ์—ผ์ฆ๊ณผ ๋ฉด์—ญ ๋ฐ˜์‘์ด ์ง€์†๋˜์–ด์„œ ์ •์ƒ์ ์ธ ์œ„์‚ฐ ๋ถ„๋น„๊ฐ€ ์ž˜ ์•ˆ ๋จ, ์œ„๊ฐ€ ์ž˜ ๋Š˜์–ด๋‚˜์ง€ ์•Š์Œ.
    • ์กฐ๊ธˆ๋งŒ ๋จน์–ด๋„ ๊ฑฐ๋ถํ•จ ๋“ฑ๋“ฑ
  • Granulomatous gastritis : ์œก์•„์ข…์„ฑ ์œ„์—ผ, ์œ„๋ฒฝ์˜ ๋น„ํ›„
    • Ollulanus tricuspis (์„ ํ˜• ๊ธฐ์ƒ์ถฉ) : ๊ณ ์–‘์ด์—์„œ ๋งŽ๊ณ , ํ˜„๋ฏธ๊ฒฝ์œผ๋กœ๋งŒ ๋ณผ ์ˆ˜ ์žˆ์Œ.
    • ํ† ์‚ฌ๋ฌผ์„ ํ˜„๋ฏธ๊ฒฝ ๊ฒ€๊ฒฝ.

Clinical Features

  • More common in cats
  • Hyporexia, vomiting
    • ๊ตฌํ†  ๋นˆ๋„๋Š” ์ฃผ 1ํšŒ๋ถ€ํ„ฐ ํ•˜๋ฃจ์—๋„ ์—ฌ๋Ÿฌ ๋ฒˆ๊นŒ์ง€ ๋‹ค์–‘, ํšŸ์ˆ˜๋กœ ๊ธ‰์„ฑ๊ณผ ๋งŒ์„ฑ์„ ๊ตฌ๋ถ„ํ•˜๊ธฐ๋Š” ์–ด๋ ค์›€.

Diagnosis

  • Blood work : Eosinophilia, but ํ˜ˆ๊ฒ€์œผ๋กœ๋Š” ํŒ๋‹จํ•˜๊ธฐ ์–ด๋ ค์›€,
  • Ultrasound : mucosal thickening
  • Endoscopy (๋‚ด์‹œ๊ฒฝ) : ์ง„๋‹จ ๊ฐ€์น˜๊ฐ€ ๊ฐ€์žฅ ๋†’์Œ. ๊ฐ€์žฅ ๊ฒฝ์ œ์ ์ด๋ฉด์„œ ํšจ์œจ์ .
  • ์—ฌ๋Ÿฌ ๊ตฐ๋ฐ์—์„œ mucosal biopsy ์‹œํ–‰.
    • ์œ ๋ฌธ๋ถ€์—์„œ 4๊ฐœ, ์ „์ •๋ถ€์—์„œ 4๊ฐœ๊ฐ€ ๊ธฐ๋ณธ + ๋ณ‘๋ณ€์ด ์žˆ๋А ๊ฒฝ์šฐ ์ถ”๊ฐ€๋กœ 2๊ฐœ์”ฉ.
  • Gastric lymphoma๋Š” ์นจ์œค์„ฑ ์ข…์–‘
    • Lymphoma์˜ ์œ„์Œ์„ฑ๋„ ๊ณ ๋ คํ•ด์•ผ ํ•จ. ์ˆ˜์ˆ ๋กœ ์ „์ธต ์ƒ๊ฒ€ํ•˜๋Š” ๊ฒƒ์ด ๊ฐ€์žฅ ์ •ํ™•ํ•œ ์ง„๋‹จ.

์ข…์–‘

  • ์นจ์œค์„ฑ ์ข…์–‘(๋„๋ฆฌ ํผ์ ธ์„œ, ์—ผ์ฆ์ฒ˜๋Ÿผ ๋ณด์ž„, ์œก์•ˆ ํŒ๋‹จ ์–ด๋ ค์›€) - adenocarcinoma, lymphoma
  • ํŒฝ์ฐฝ์„ฑ ์ข…์–‘ (solitary, ๊ตญ์†Œ์ ์œผ๋กœ ์ž๋žŒ, ์šฑ์•ˆ ํŒ๋‹จ ๊ฐ€์‰ฌ์›€) - myosarcoma
  • ๊ทผ์œก์ด๋‚˜ ์ ๋ง‰ ํ•˜์ธต ๊นŠ์€ ๊ณณ์— ์ž๋ž€ ๊ฒฝ์šฐ, ์œ„์ธต๋งŒ ๋–ผ๋ฉด ์—ผ์ฆ ์†Œ๊ฒฌ์œผ๋กœ ๋‚˜์˜ฌ ์ˆ˜๋„.
  • ํ™•์ง„์„ ์œ„ํ•ด์„œ๋Š” ์ „์ธต ์ƒ๊ฒ€ โ‡’ ์กฐ์ง๊ฒ€์‚ฌ ํ•„์š”

Treatment

Type
LP gastritis1๏ธโƒฃ Diet therapy : ์•Œ๋Ÿฌ์ง€ ์—†๋Š” ์‹์ด๋งŒ ์œ ์ง€.
- Elimination diets (์ œํ•œ ์‹์ด) : ๊ณต์ •์ด ๋˜์–ด ์žˆ๋Š” ์‚ฌ๋ฃŒ๋งŒ ๊ณ„์† ๋จน๋Š” ๊ฒƒ.
- ์†Œํ™”๊ฐ€ ์ž˜ ๋˜๋Š” ์‹์ด : low-fat, low-fiber (๊ธฐ๋ฆ„์ง„ ๊ฒƒ X, ์„ฌ์œ ์†Œ X)
2๏ธโƒฃ Concurrent coticosteroid (PDS 2.2mg/kg/day โ†’ tapering off)
- ์ดˆ๊ธฐ์—๋Š” ์Šคํ…Œ๋กœ์ด๋“œ๋ฅผ ํฌํ•จํ•œ ์•ฝ์ด ํšจ๊ณผ ์ข‹์œผ๋‚˜, ์ฒœ์ฒœํžˆ tapering ํ•˜๋Š” ๊ฒŒ ์ค‘์š”!
(๋ณดํ˜ธ์ž๊ฐ€ ์ž„์˜๋กœ ๊ฐ‘์ž๊ธฐ ๋‹จ์•ฝํ•˜์ง€ ์•Š๋„๋ก.. ์•ˆ ๊ทธ๋Ÿผ ๋‚˜์ค‘์— ๋ฐ˜์‘์„ฑ ๋–จ์–ด์ง. ๋Œ€๋ถ€๋ถ„ 2์ฃผ์— 25%์”ฉ ์ค„์—ฌ ๊ฐ.)
3๏ธโƒฃ Concurrent Hโ‚‚ blocker ๋˜๋Š” PPi : ์œ„์‚ฐ ์–ต์ œ
- PPi : ์œ„์‚ฐ์„ ์ž˜ ์–ต์ œํ•จ. (์œ„์‚ฐ์„ ๊ฐ•๋ ฅํ•˜๊ฒŒ ์–ต์ œํ•˜๋ฏ€๋กœ, 4์ฃผ ์ด์ƒ ์‚ฌ์šฉํ•˜๋ฉด ์†Œ์žฅ์— ์„ธ๊ท  ๊ณผ์ฆ์‹์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ์Œ.)
- ํšจ๊ณผ๊ฐ€ ๋‚ฎ์•„๋„ ์ž”์ž”ํ•˜๊ฒŒ ๊ฒŒ์† ์“ฐ๊ณ  ์‹ถ์œผ๋ฉด H2 blocker๋„ ์ข‹์Œ.
Eosinophilic gastritis- ์†Œํ™”๊ฐ€ ์ž˜ ์•ˆ ๋˜๋Š” ์ƒํƒœ.
- ์™„์ „ํ•œ ์น˜๋ฃŒ๋Š” ์–ด๋ ต๊ณ , ์ œํ•œ ์‹์ด ๋‹จ๋… ๊ณต๊ธ‰ (Strict elimination diet)
- Concurrent corticosteriod (PDS 1.1-2.2mg/kg/day)
Atrophic gastriris /
Granulomatous gastritis
- Difficult to treat : ๋งŒ์„ฑ ์—ผ์ฆ์ด ํ‰ํ„ฐ๋กœ ๋‚จ์€ ๋น„๊ฐ€์—ญ์  ์ƒํƒœ
- ์†Œํ™” ํšจ์†Œ ๋ถ„๋น„๊ฐ€ ์–ด๋ ค์šฐ๋‹ˆ low-fat, low-fiber diet

Prognosis

  • LP : ์ข‹์Œ. (๋ชฉ์ˆจ์— ์˜ํ–ฅX)
  • Eosinophilc gastritis
    • ๊ฐœ์—์„œ๋Š” ์ข‹์œผ๋‚˜
    • ๊ณ ์–‘์ด๋Š” ์‹์ด์— ์˜ํ•œ ๊ฒƒ์ด ์•„๋‹ ๊ฒฝ์šฐ, hypereosionophilic syndrome ์ด ๋™๋ฐ˜๋˜๋ฉด ์˜ˆํ›„ ๋งค์šฐ ์•ˆ ์ข‹์Œ
  • Atrophic gastritis, granulomatous gastritis : Not bad (์™„์น˜๋Š” ์–ด๋ ต์ง€๋งŒ, ์‚ฌ๋งํ•˜์ง€๋Š” ์•Š์Œ)

2.4 Helicobacter-associated Dz

Etiology

  • ์‚ฌ๋žŒ์—์„œ ํ—ฌ๋ฆฌ์ฝ”๋ฐ•ํ„ฐ ๊ฐ์—ผ์ฆ์€ ์œ„์•”์œผ๋กœ ์ง„ํ–‰๋  ์ˆ˜ ์žˆ์ง€๋งŒ, ๊ฐœ์™€ ๊ณ ์–‘์ด์—์„œ๋Š” ํ™•์‹คํ•˜์ง€ ์•Š์Œ (์•„๋‹ˆ๋ผ๊ณ  ์ถ”์ธก)
  • Principal Spirochete gastric mucosa (๋‚˜์„ ํ˜• ํ˜•ํƒœ)
    • Helicobacter pylori (human, rarely in cats / ๊ฐœ์—์„œ๋Š” X)
    • Helicobacter felis (D, C)
    • Helicobacter heilmannii (D, C)
    • Helicobacter bizzozeronii (D, C)
    • Helicobacter salomonis (D, C)
  • giemsa โ†’ ํŒŒ๋ž€์ƒ‰, silver staining โ†’ ๊ฒ€์€์ƒ‰์œผ๋กœ ์—ผ์ƒ‰๋จ

Clinical Features

  • ์‚ฌ๋žŒ์—์„œ H. pylori ๊ฐ์—ผ

    • Asymptomatic
    • Low-grade MALT lymphoma (Mucosal-associated lymphoid tissue)
      • ์ ๋ง‰์—๋งŒ ๋ถ„ํฌํ•˜๋Š”, ๋А๋ฆฌ๊ฒŒ ์ž๋ผ๋Š” ์•”. ์นจ์œค์„ฑ์ด ๋‚ฎ๊ณ , B lymphocyte ํ˜•์„ฑ
  • ๊ฐœ์™€ ๊ณ ์–‘์ด์—์„œ, gastric helicobacter ๊ฐ์—ผ

    • Asymptomatic (์ฆ์ƒ์ด ์—†์œผ๋ฉด ์น˜๋ฃŒํ•˜์ง€ ์•Š์•„๋„ ๋จ)
    • Nausea(๋ฉ”์Šค๊บผ์›€), anorexia, vomiting
    • ๊ณ ์–‘์ด์—์„œ low-grade lymphoma๊ฐ€ ๋ฐœ์ƒ โ†’ ํ•ญ์•”์ œ (์—ฐ๊ด€์„ฑ ๋–จ์–ด์ง) / ์ฃผ๋กœ T lymphocyte ํ˜•์„ฑ
์‚ฌ๋žŒ ์น˜๋ฃŒ๊ฐœ/๊ณ ์–‘์ด ์น˜๋ฃŒ
์ œ๊ท  ์น˜๋ฃŒ๊ฐ€ ๋ชฉ์  + ์ œ์‚ฐ์ œ(์œ„์—ผ ์™„ํ™”)
์‚ฌ๋žŒ์—์„œ ํ›จ์”ฌ ์‹ฌ๊ฐํ•จ.
์ œ๊ท ์ด ๋ชฉ์ ์ด ์•„๋‹ˆ๋ฏ€๋กœ,
์ฆ์ƒ์ด ์—†์œผ๋ฉด ์น˜๋ฃŒํ•˜์ง€ ์•Š์•„๋„ ๋จ.
ํ•ญ์ƒ์ œ ์น˜๋ฃŒ (PPi + Clarithromycin + AMC)
: penicillin ์•Œ๋Ÿฌ์ง€ ์žˆ์„ ์‹œ AMC ๋Œ€์‹  metronidazole
ํ•ญ์ƒ์ œ ์น˜๋ฃŒ (PPi + AMC + metronidazole)
: clarithromycin์€ ๋น„์Œˆ.

Diagnosis

  • Gastric biopsy w/ histopathology

    • Silver stain โ†’ Helicobacter๊ฐ€ ๋ช…ํ™•ํ•˜๊ฒŒ ๊ฒ€์ •์œผ๋กœ ๋ณด์ž„. (but ์š”์ฆ˜ ์ž˜ ์•ˆ ํ•จ)
    • Giemsa stain โ†’ ํŒŒ๋ž€์ƒ‰์œผ๋กœ ๋ณด์ž„ (์ผ๋ฐ˜์ )
    • Multiple biopsy ํ•„์š”
  • Gastric mucosal urease activity test

    • ์œ„(๊ฐ•ํ•œ ์‚ฐ์„ฑ ํ™˜๊ฒฝ)์— ์„œ์‹ํ•˜๋Š” ์„ธ๊ท ์€ ์ฃผ๋ณ€์„ ์•Œ์นผ๋ฆฌํ™”ํ•˜์—ฌ ์ƒ์กด ๊ฐ€๋Šฅํ•œ ๊ฒƒ
    • ์ฃผ๋ณ€์— urease๋ฅผ ๋ถ„๋น„ โ†’ ์ฒด๋‚ด urea๋ฅผ ๋ถ„ํ•ดํ•˜์—ฌ ์•”๋ชจ๋‹ˆ์•„ ํ˜•์„ฑ โ†’ pH ์ƒ์Šน
    • ๊ทธ๋ž˜์„œ urease activity test๊ฐ€ gold standard test (๋ฏผ๊ฐ๋„์™€ ํŠน์ด๋„ > 90%)
      • Gastric mucosa (2pcs) + urease test agar (24h) โ‡’ ํ‚คํŠธ์— ์žˆ๋Š” phenol red์— ์˜ํ•ด pink๋กœ ๋ฐ”๋€œ.
      • Phenol red : ์›๋ž˜ ๋…ธ๋ž€์ƒ‰, ์ค‘์„ฑ ์ด์ƒ pH ์ƒ์Šนํ•˜๋ฉด ๋ถ‰์€์ƒ‰-ํ•‘ํฌ์ƒ‰์œผ๋กœ ๋ฐ”๋€œ. ์—ฌ๊ธฐ์— Helicobacter์— ๊ฐ์—ผ๋œ ์ ๋ง‰์„ ๋„ฃ์œผ๋ฉด, urease์— ์˜ํ•ด ๋ถ‰์€์ƒ‰์œผ๋กœ ๋ฐ”๋€œ.
  • Campilobacter-like organism. : helicobacter ์ง„๋‹จ์šฉ.

Treatment & Prognosis

  • PPi + metronidazole + ์•„๋ชจํฌ๋ผ(Amoxicillin+Clavulanic acid)
    • ์•„๋ชจํฌ๋ผ ๋Œ€์‹  Azithromycin / Chlarithromycin ๊ฐ€๋Šฅ (AMC ํšจ๊ณผ ์—†๋Š” ๊ฒฝ์šฐ)
  • ์ตœ์†Œ 14์ผ ์ฒ˜๋ฐฉ
  • ์˜ˆํ›„๋Š” good

2.5 Pyloric stenosis (์œ ๋ฌธ๋ถ€ ํ˜‘์ฐฉ)

Etiology

  • ๋ช…ํ™•ํ•˜๊ฒŒ ํ™•๋ฆฝ๋˜์ง„ ์•Š์•˜์œผ๋‚˜, benign muscular pyloric hypertrophy

Clinical Features

  • Projectile vomiting (๋ฟœ์–ด๋‚ด๋“ฏ ๊ฐ•๋ ฅํ•œ ํ† ), shortly after eating
  • ์–ด๋ฆฐ ๋™๋ฌผ์—์„œ persistent vomiting
    • ๋จน๋Š” ์–‘์ด ์ ์€ ํ’ˆ์ข…์—์„œ ํ˜ธ๋ฐœ.
    • Brachycephalic dogs, Siamese cats
  • ์ฒด์ค‘ ๊ฐ์†Œ or nomal.
  • ๊ตฌํ† ๋ฅผ ๊ณ„์† ํ•˜๋ฉด HCl ์†Œ์‹ค โ†’ hypochloremic-hypokalemic metabolic alkalosis (๋งค์šฐ ๋น„ํŠน์ด์ ์ž„)
    • ์œ„์‚ฐ์ด ์ฒด์™ธ๋กœ ๋‚˜๊ฐ€ Cl ๋ถ€์กฑํ•ด์ง€๋‹ˆ๊นŒ hypochloremic (alkalosis)
    • H๋ฅผ ๋ถ„๋น„ํ•˜์—ฌ ์•Œ์นผ๋ฆฌ์ฆ์„ ์ค‘ํ™” โ‡’ ์นผ๋ฅจ๊ณผ ๊ตํ™˜ํ•˜์—ฌ hypokalemic
      • ์นผ๋ฅจ๊ณผ ์‚ฐ(H) ๊ตํ™˜: ์„ธํฌ์™ธ์•ก์˜ ์นผ๋ฅจ์ด ์„ธํฌ๋กœ ๋“ค์–ด์˜ค๊ณ , ์‚ฐ์ด ๋‚˜๊ฐ€๋ฉด์„œ ํ˜ˆ์•ก์˜ ์นผ๋ฅจ ์ ์–ด์ง.

Diagnosis

  • Finding gastric outflow obstruction
    • ์˜์ƒ ๊ฒ€์‚ฌ ๋ฐ ์กฐ์˜ ๊ฒ€์‚ฌ๋กœ ์œ ๋ฌธ๋ถ€๊ฐ€ ๋ง‰ํ˜€์žˆ๋Š” ๊ฒƒ์„ ํ™•์ธ.
    • ๋งŒ์กŒ์„ ๋•Œ ์œ ๋ฌธ๋ถ€๊ฐ€ ๋‹จ๋‹จํ•˜๊ฒŒ ๋А๊ปด์ง, ์œ ๋ฌธ๋ถ€์— ์†๊ฐ€๋ฝ์ด ์ž˜ ํ†ต๊ณผ๋˜์ง€ ์•Š์œผ๋ฉด ์ข€ ๋ง‰ํžŒ ๊ฒƒ.
  • Biopsy : infiltrative pyloric disease r/o
  • Endoscopy : ์œ ๋ฌธ๋ถ€ ์ฃผ๋ฆ„์ด ์šธ๋ฃฉ๋ถˆ๋ฃฉ ๋ถ€์–ด ์žˆ์–ด ์•”์ฒ˜๋Ÿผ ๋ณด์ผ ์ˆ˜ ์žˆ์Œ.
    • ํ•˜์ง€๋งŒ ๋‚˜์ด๊ฐ€ ์–ด๋ฆฌ๊ณ , ์ฃผ๋ณ€์— ์—ผ์ฆ์ด ์—†์œผ๋ฉด ์œ ๋ฌธ๋ถ€ํ˜‘์ฐฉ์„ ์˜์‹ฌ.
  • ๊ตฌํ† ์˜ ๋‹ค๋ฅธ ์›์ธ์„ ๊ฐ๋ณ„ํ•˜๊ณ , ์ง„๋‹จ๊ณผ ์น˜๋ฃŒ๋ฅผ ์œ„ํ•ด ํƒ์ƒ‰์  ๊ฐœ๋ณต์ˆ  ๊ฐ€๋Šฅ

๊ตฌํ† ๋ฅผ ์œ ๋ฐœํ•˜๋Š” ๋‹ค๋ฅธ alimentary tract disease๋ฅผ ๊ฐ๋ณ„ํ•˜๋Š” ๊ฒƒ์ด ์ค‘์š”!

Treatment

  • Surgical correction : ์ข์€ ๋‚ด๊ฐ•์„ ๋„“๊ฒŒ
    • Pyloroplasty (Y-U-plasty) : ์„ฑํ˜•์ˆ ์ด ์ข€ ๋” ์˜ˆํ›„ ์ข‹์€ ํŽธ์ด๋ผ ์„ ํ˜ธ๋จ.
    • Pyloromyotomy (์œ ๋ฌธ๋ถ€ ์ ˆ์ œ)

Prognosis

  • ์ˆ˜์ˆ ํ•˜๋ฉด good.

2.6 Gastric foreign bodies

Etiology

  • ์‹๋„๋ฅผ ํ†ต๊ณผํ•œ ์ด๋ฌผ์— ์˜ํ•ด
  • ์„ ํ˜• ์ด๋ฌผ : ๊ฐ€์žฅ ์œ„ํ—˜.
    • ๊ณ ์–‘์ด๋Š” ํ˜€์— ๋Œ๊ธฐ๊ฐ€ ์žˆ์–ด์„œ ์‹ค ๊ฐ™์€ ๊ฒŒ ํ•œ๋ฒˆ ๊ฐ๊ธฐ๋ฉด ๋ฑ‰๊ธฐ ์–ด๋ ค์›€.
    • ์—ฐ๋™์šด๋™์œผ๋กœ ๊ณ„์† ์•„๋ž˜๋กœ ๋‹น๊ธฐ๋Š” ํž˜์ด ์žˆ์Œ. ์‚ผํ‚ค์ง€ ์•Š์œผ๋ฉด ์žฅ์ด ์—ฐ๋™์šด๋™์— ์˜ํ•ด ์˜คํžˆ๋ ค ๋Œ๋ ค์˜ฌ๋ผ์˜ค๋ฉด์„œ ์ ๋ง‰์ด ๊ฒน์นจ, ๊ดด์‚ฌ, ์ฒœ๊ณต..

Clinical Features

  • Dogs > Cats
  • ๊ตฌํ†  (not regurgitation)
  • ์–ด๋ฆฐ ๊ฐ•์•„์ง€ ๊ตฌํ†  โ†’ ์ด๋ฌผ or ํŒŒ๋ณด.
    • ํŒŒ๋ณด ์ดˆ๊ธฐ์—๋Š” ๊ตฌํ† ๋งŒ ํ•˜๋‹ค๊ฐ€, 4-5์ผ์ฏค ์ง€๋‚˜๋ฉด ์„ค์‚ฌ. ๊ทธ๋•Œ๊นŒ์ง„ ๋ถ„๋ณ€๊ฒ€์‚ฌํ•ด๋„ ๊ฒ€์ถœ๋˜์ง€ ์•Š์Œ.

ํŒŒ๋ณด๋ฐ”์ด๋Ÿฌ์Šค ์œ„์Œ์„ฑ ์ฃผ์˜!

  • ์ดˆ๊ธฐ ๊ตฌํ† ๋งŒ ํ•  ๋•Œ๋Š” ํŒŒ๋ณด ์Œ์„ฑ์ด์—ˆ๋‹ค๊ฐ€, ์–‘์„ฑ์ด ๋  ์ˆ˜ ์žˆ์Œ.
  • ๊ฒ€์‚ฌ๋ฅผ ๊ณ„์† ํ•ด์•ผ ํ•˜๋Š” ๊ฒƒ์„ ๊ผญ ์•ˆ๋‚ดํ•ด์•ผ ํ•จ.

Diagnosis

  • Signalment, P/E (์ƒ๋ณต๋ถ€ ํŒฝ๋งŒ, ํ†ต์ฆ)
  • Blood โ†’ Hypokalemic-hypochloremic metabolic alkalosis (๋น„ํŠน์ด์ )
  • Plain radiography๋งŒ์œผ๋กœ ์ง„๋‹จํ•˜๊ธฐ ์–ด๋ ค์šด ์ด๋ฌผ๋„ ๋งŽ๋‹ค.
  • Endoscopy

Treatment

  • Endoscopically or surgically removal
    • ์ด์‘ค์‹œ๊ฐœ์ฒ˜๋Ÿผ ๋์ด ๋พฐ์กฑํ•˜๊ณ  ์ž˜ ์žกํžˆ์ง€ ์•Š๋Š” ๊ฒฝ์šฐ๋Š” ์ˆ˜์ˆ ์  ์ œ๊ฑฐ ํ•„์š”.
    • ๊ทธ๋ƒฅ ์ž˜ ์žกํžˆ๋Š” ์ด๋ฌผ์ด๋ฉด ๋‚ด์‹œ๊ฒฝ์œผ๋กœ ์ œ๊ฑฐ.
  • ๊ตฌํ†  ์œ ๋ฐœ
    • Dogs - apomorphine : ๊ฐœ์—์„œ ํšจ๊ณผ ์ข‹์Œ
    • Cats - xylazine : ์›๋ž˜ ์ง„์ •์ œ. ๊ตฌํ† ์œ ๋ฐœ๋„ ๋˜์ง€๋งŒ ์ง„์ • ํšจ๊ณผ๋„ ์žˆ์–ด ์กฐ์‹ฌ์Šค๋Ÿฝ๊ฒŒ ์”€.
    • Hydrogen peroxide 3% : ๊ณ ์–‘์ด๋Š” ์“ฐ๋ฉด ์•ˆ๋จ. ์œ„๋ฅผ ์ž๊ทนํ•ด์„œ ๊ตฌํ† ๋ฅผ ์œ ๋ฐœํ•˜๋Š” ๊ฑฐ๋ผ ์ข‹์ง„ ์•Š์Œ. ์œ„์—ผ ๊ฐ€๋Šฅ์„ฑ๋„ ์žˆ์Œ. ์“ธ ๊ฒŒ ์—†๋Š”๋ฐ ๋„ˆ๋ฌด ๊ธ‰ํ•œ ์ƒํ™ฉ ๋“ฑ์—์„œ๋งŒ ์‚ฌ์šฉ.
    • Contraindications | sharp edges (์†์ƒ ์œ„ํ—˜), small object (๋ณ€์œผ๋กœ ๋‚˜์˜ฌ ๋•Œ๊นŒ์ง€ ๊ธฐ๋‹ค๋ฆผ)

Prognosis

  • ์ž˜ ์ œ๊ฑฐ๋˜๋ฉด ์˜ˆํ›„ ์ข‹์Œ.

2.7 Bilious vomiting syndrome

์ŠคํŽ ๋ง ์กฐ์‹ฌ!

Etiology

  • Gastroduodenal reflux due to empty stomach
  • ๋ฐค ์‚ฌ์ด ๋„ˆ๋ฌด ๊ตถ์–ด์„œ ์ƒ๊น€. ์˜ˆํ›„ ์ข‹์Œ.

Clinical Features

  • ๊ฑฐํ’ˆ์ด ์„ž์ธ ์ดˆ๋ก์ƒ‰ ๊ตฌํ†  (๋‹ด์ฆ™ ๊ตฌํ† )
  • ์•„์นจ์— ๋จน์—ˆ๋Š”๋ฐ ๋‚ด๋‚ด ๊ตถ์—ˆ์Œ โ†’ ๋จน์€ ๊ฒƒ ์—†์ด ์Œ“์ธ ๋‹ด์ฆ™์ด ์œ„๋ฅผ ์ž๊ทนํ•ด์„œ ๊ตฌํ† .
  • ์•„์นจ์— ๋‹ค์Œ ๋ฐฅ ๋จน๊ธฐ ์ง์ „์— ํ† ํ•˜๋Š” ๊ฒฝ์šฐ ๋งŽ์Œ.

Diagnosis

  • ๋‹ค๋ฅธ ์›์ธ ๋ฐฐ์ œ + History
    • GI inflammation, extra-alimentary tract disease

Treatment

  • prokinetic - ์—ฐ๋™์šด๋™ ์ด‰์ง„
  • ๋ฐฅ์„ ํ•œ ๋ผ ๋” ๋จน์ด๊ธฐ
  • ์˜ˆํ›„ Excellent.

2.8 Gastric Neoplasms

Etiology

  • Benign gastric polyps

    • ์œ„์˜ ์ „์ •๋ถ€์— ๋งŽ์ด ๋ฐœ์ƒ.
    • ์šฉ์ข…์ด ๋ฌผ๋ฆฌ์ ์œผ๋กœ ์œ ๋ฌธ์„ ๋ง‰์œผ๋ฉด ๋–ผ์•ผ ํ•  ์ˆ˜๋„.
    • ์ฆ์ƒ๋„ ์—†๊ณ , ๊ผญ ๋–ผ์•ผ ํ•˜๋Š” ๊ฒƒ๋„ ์•„๋‹ˆ๊ณ , ์šฐ์—ฐํžˆ ๋ฐœ๊ฒฌ๋  ๋•Œ๊ฐ€ ๋งŽ๋‹ค.
  • ๊ฐœ์—์„œ๋Š” ์œ„์—์„œ ๋‹ค์–‘ํ•œ ์•”

    • Adenocarcinoma
    • Lymphoma
    • Leiomyomas โ†’ ํŒฝ์ฐฝ์„ฑ, ๊ถค์–‘์— ์˜ํ•œ ์ถœํ˜ˆ์„ ๋งŽ์ด ์œ ๋ฐœ. (์‹œ๊ฐ„์ด ์ง€๋‚˜๋ฉด ๋งŒ์„ฑ์ ์ธ ์ฒ ๋ถ„ ๊ฒฐํ•)
    • Leiomyosarcomas โ†’ ์นจ์œค์„ฑ, ์น˜๋ฃŒ ๋” ์–ด๋ ค์›€
    • Stromal tumors (ex. GIST)
  • ๊ณ ์–‘์ด์—์„œ๋Š” ์œ„์—์„œ lymphoma๊ฐ€ ์ œ์ผ ์ค‘์š”.


  • ์นจ์œค์„ฑ ์ข…์–‘์€ ์—ฌ๊ธฐ์ €๊ธฐ ํผ์ ธ ์žˆ์–ด์„œ ์ˆ˜์ˆ ์ด ์–ด๋ ค์›€.

  • ํŒฝ์ฐฝ์„ฑ ์ข…์–‘์€ ๊ตญ์†Œ์ ์œผ๋กœ ๊ฒฝ๊ณ„๊ฐ€ ํ™•์‹ค, ๊ทผ์œก์ธต์—์„œ ์ƒ๊ธด ๊ฒŒ ์ ๋ง‰์„ ๋ˆ„๋ฅด๊ฑฐ๋‚˜ ํ•ด์„œ ๊ถค์–‘์ด ์ž˜ ์ƒ๊น€.

Clinical features

  • ์‹์š• ๋ถ€์ง„, ๊ตฌํ† 
  • ์œ„์•”์˜ ๊ฒฝ์šฐ, ์ฆ์ƒ์ด ๋งŽ์ด ์ƒ๊ฒจ์„œ ์ง„๋‹จํ•œ ๋’ค์—๋Š” ์ด๋ฏธ ๋Šฆ์–ด์„œ ์ง„๋‹จ์ด ์–ด๋ ค์šธ ๋•Œ๊ฐ€ ๋งŽ์Œ.
  • ํ† ํ˜ˆ (hematemesis) โ†’ Leiomyomas
    • (๊ตฌํ† ๋ฅผ ๊ฐ€์žฅ ๋งŽ์ด ์œ ๋ฐœํ•จ, ๊ทผ์œก์ธ ์—ฅ ์ƒ๊ธฐ๋Š” ํŒฝ์ฐฝ์„ฑ ์ข…์–‘.)

Diagnosis

  • ๋Œ€๋ถ€๋ถ„ ์„œ์„œํžˆ ๋งŒ์„ฑ์ ์œผ๋กœ ์ƒ๊ธฐ๋Š” ์ถœํ˜ˆ๋กœ, ์ฒ  ๊ฒฐํ•์„ฑ ๋นˆํ˜ˆ์ด ์ƒ๊น€.
  • Plain & Contrast : Gastric wall thickening, ๋ถˆ๊ทœ์น™ํ•œ ์ ๋ง‰, ์šด๋™์„ฑ ๋–จ์–ด์ง
  • FNA ์ง„๋‹จ ์‹œ ์ตœ๋Œ€ํ•œ ์ ๋ง‰์ธต ๊นŠ์ด
    • Leiomyoma, leiomyosarcoma ๋Š” FNA๋กœ ์ง„๋‹จํ•˜๊ธฐ ์–ด๋ ค์›€.

Treatment & Prognosis

  • Adenocarcinoma ; ์นจ์œค์„ฑ ์ข…์–‘์œผ๋กœ ์ ˆ์ œ๊ฐ€ ๋ถˆ๊ฐ€๋Šฅ, ์ „์ด๊ฐ€ ์ž˜ ๋จ, ์™„์ „ํ•œ ์น˜๋ฃŒ๋Š” ๋ถˆ๊ฐ€๋Šฅ. ์ถ”๊ฐ€ ํ•ญ์•”์น˜๋ฃŒ ๋ถˆ๊ฐ€, ํ•˜๋งŒ ํ•ญ์•” ์น˜๋ฃŒ์— ๋ฐ˜์‘์ด ์ž˜ ์—†๋Š” ํŽธ. ์˜ˆํ›„ poor.

  • Leiomyoma : ํŒฝ์ฐฝ์„ฑ, ๊ฒฝ๊ณ„๊ฐ€ ๋ถ„๋ช…, ์ ˆ์ œ ๊ฐ€๋Šฅ

  • Leiomyosarcomas : ๊ตญ์†Œ์นจ์œค์„ฑ, ์ „์ด๊ฐ€ ์ž˜ ์—†๊ฑฐ๋‚˜ ๋А๋ฆผ, ์–ด๋А ์ •๋„ ๊ฒฝ๊ณ„๊ฐ€ ์žˆ๊ณ  ์ง„ํ–‰์ด ๋А๋ฆผ, ์ดˆ๊ธฐ์— ๋ฐœ๊ฒฌ ์‹œ ์ˆ˜์ˆ  ๊ฐ€๋Šฅํ•  ๊ฐ€๋Šฅ์„ฑ

  • Chemotherapy : lymphoma๋ฅผ ์ œ์™ธํ•œ ์•”์—์„œ๋Š” ์ž˜ ๋ฐ˜์‘ ์—†์Œ.

  • Gastricpolyps : ์ ˆ์ œํ•  ํ•„์š” ์—†์Œ.

  • Lymphoma ion dogs : ์™„์ „ ์ ˆ์ œ ๋ถˆ๊ฐ€๋Šฅ, ์žฌ๋ฐœ ๊ฐ€๋Šฅ์„ฑ ๋†’์Œ, ์˜ˆํ›„ ์•ˆ ์ข‹์Œ.

  • Lymphoma in cats : ์‚ฌ๋žŒ์—์„œ ๋ฐœ์ƒํ•˜๋Š” MALT-associated lymphoma(B์„ธํฌ ์œ ๋ž˜)์™€ ์œ ์‚ฌ.

    • ๊ณ ์–‘์ด์—์„œ ๋ฐœ์ƒํ•˜๋Š” low-grade lymphoma๋Š” T์„ธํฌ ์œ ๋ž˜.
    • ๊ณ ์–‘์ด์—์„œ๋Š” ์ฃผ๋œ ์›์ธ์ด ์•„๋‹ˆ๊ธฐ ๋•Œ๋ฌธ์— helicobacter ์น˜๋ฃŒ๊ฐ€ ์„ ํƒ.
    • ๊ณ ์–‘์ด์—์„œ ์ œ๊ท  ์น˜๋ฃŒ๊ฐ€ ์–ด๋ ค์›Œ ๊ฒฝ๊ตฌ ํ•ญ์•” ์น˜๋ฃŒ๋กœ ์žฅ๊ธฐ ๊ด€๋ฆฌ(chlorambucil + PDS) โ†’ ์ง„ํ–‰์ด ๋А๋ฆฌ๊ธฐ ๋•Œ๋ฌธ์— ์ˆ˜ ๋…„ ์ƒ์กด ๊ฐ€๋Šฅ.
    • ์˜ˆํ›„๊ฐ€ ์ข‹์€ ํŽธ